SCHEMBL563456

SCHEMBL563456

O=C(O)NNc1ccnc(Cl)c1[N+](=O)[O-]

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
LMNA P02545 4/20 0.40
MAPT P10636 5/20 0.38
KMT2A Q03164 4/20 0.38
POLB P06746 2/20 0.38
KDM4E B2RXH2 2/20 0.38
CASP3 P42574 1/20 0.38
RECQL P46063 1/20 0.38
MCL1 Q07820 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
HTT P42858 4/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
GAA P10253 3/20 0.35
CA1 P00915 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL563457 1.00 ALDH1A1 (0.40) ALDH1A1LMNAMAPTKMT2APOLB
SCHEMBL562919 0.80 ATR (0.44) ALDH1A1LMNAMAPTKMT2APOLB
SCHEMBL2708359 0.80 ALDH1A1 (0.38) ALDH1A1LMNAMAPTKMT2AKDM4E
SCHEMBL1742858 0.78 MAPT (0.39) ALDH1A1LMNAMAPTKMT2ATDP1
SCHEMBL1742856 0.78 MAPT (0.39) ALDH1A1LMNAMAPTKMT2ATDP1
SCHEMBL12138409 0.76 ALDH1A1 (0.44) ALDH1A1LMNAMAPTKMT2APOLB
SCHEMBL801406 0.74 SMN1; SMN2 (0.50) ALDH1A1LMNAMAPTKMT2AKDM4E
SCHEMBL31092297 0.74 SMN1; SMN2 (0.50) ALDH1A1LMNAMAPTKMT2AKDM4E
SCHEMBL18803141 0.73 ALDH1A1 (0.36) ALDH1A1LMNAMAPTKMT2APOLB
SCHEMBL7885090 0.73 LMNA (0.41) ALDH1A1LMNAMAPTPOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120035209-A1 Hydroxy Substituted 1H-Imidazopyridines and Methods PFIZER INC. (US) 2012-02-09 US disclosed
EP-1924581-A1 HYDROXY SUBSTITUTED 1H-IMIDAZOPYRIDINES AND METHODS Pfizer, Inc. (US) 2008-05-28 EP disclosed
WO-2007028129-A1 HYDROXY SUBSTITUTED 1H-IMIDAZOPYRIDINES AND METHODS PFIZER INC. (US) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035209-A1 Hydroxy Substituted 1H-Imidazopyridines and Methods IL2, IL4, IL4I1 ALDH1A1 623/4885LMNA 3173/4885MAPT 4506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.